{"id":14251,"date":"2023-01-24T13:54:55","date_gmt":"2023-01-24T18:54:55","guid":{"rendered":"https:\/\/jasonapollovoss.com\/web\/?p=14251"},"modified":"2025-09-05T14:53:08","modified_gmt":"2025-09-05T20:53:08","slug":"data-assessment-of-abbott-laboratories-pediatric-nutritionals","status":"publish","type":"post","link":"https:\/\/jasonapollovoss.com\/web\/2023\/01\/24\/data-assessment-of-abbott-laboratories-pediatric-nutritionals\/","title":{"rendered":"DATA Assessment of Abbott Laboratories\u2019 Pediatric Nutritionals"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;section&#8221; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_row admin_label=&#8221;row&#8221; _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;]<\/p>\n<figure class=\"x-el x-el-figure c2-1 c2-2 c2-3x c2-i c2-h c2-21 c2-2c c2-29 c2-2a c2-43 c2-51 c2-3 c2-4 c2-5 c2-6 c2-7 c2-8\">\n<div><\/div>\n<\/figure>\n<p><span style=\"font-family: futural;\">According to the Wall Street Journal on Friday, 20 January 2023,\u00a0<a class=\"x-el x-el-a c2-2w c2-2x c2-69 c2-v c2-w c2-x c2-j c2-6a c2-3 c2-30 c2-31 c2-11 c2-32\" href=\"https:\/\/www.wsj.com\/articles\/abbott-under-criminal-investigation-over-baby-formula-11674255871\" rel=\"\">the US Department of Justice is investigating Abbott Laboratories<\/a>\u00a0due to a product recall of infant formula and the subsequent shutdown of its manufacturing at its Sturgis, Michigan plant in February 2022. You may remember that there was a consequent nationwide shortage of infant formula in the spring of 2022. In turn this led to price gouging and many upset parents, and suspicions of major infant formula manufacturers.<\/span><\/p>\n<p><span style=\"font-family: futural;\">It is only natural to wonder if Abbott Labs is, or has been deceptive, about the baby formula shortage. Therefore, a check of Abbott\u2019s three 10(q)s subsequent to the recall and plant shutdown in Deception And Truth Analysis\u2019 DATAbase product makes sense. Are they, or are they not being forthright about this key business risk?<\/span><\/p>\n<p><span style=\"font-family: futural;\">Here is how we scored Abbott\u2026<\/span><\/p>\n<p><span style=\"font-family: futural;\">1. 2 May 2022 10(q)<\/span><\/p>\n<p><span style=\"font-family: futural;\">\u00a0\u00a0\u00a0a. Overall DATA Score = -14.57%<\/span><\/p>\n<p><span style=\"font-family: futural;\">\u00a0\u00a0\u00a0b. % of deceptive fragments = 85.71%<\/span><\/p>\n<p><span style=\"font-family: futural;\">2. 1 August 2022 10(q)<\/span><\/p>\n<p><span style=\"font-family: futural;\">\u00a0\u00a0\u00a0a. Overall DATA Score = -16.77%<\/span><\/p>\n<p><span style=\"font-family: futural;\">\u00a0\u00a0\u00a0b. % of deceptive fragments = 87.50%<\/span><\/p>\n<p><span style=\"font-family: futural;\">3. 31 October 2022 10(q)<\/span><\/p>\n<p><span style=\"font-family: futural;\">\u00a0\u00a0\u00a0a. Overall DATA Score = -18.14%<\/span><\/p>\n<p><span style=\"font-family: futural;\">\u00a0\u00a0\u00a0b. % of deceptive fragments = 87.50%<\/span><\/p>\n<p><span style=\"font-family: futural;\">From the above, it may seem as if the company is being deceptive, given their overall DATA Scores indicating deceptiveness. However, we found something remarkable in all three 10(q)s. Namely, that the\u00a0<em class=\"x-el x-el-span c2-2w c2-2x c2-3 c2-65 c2-13 c2-31 c2-66 c2-67\">only truthful fragments<\/em>\u00a0in each of these documents are Abbott\u2019s disclosures around its Pediatric Nutritionals, as it refers to its infant formula business. If you were a DATAbase Client you could verify this for yourself. Here is a screenshot of our DATA<strong class=\"x-el x-el-span c2-2w c2-2x c2-3 c2-65 c2-13 c2-3v c2-66\">RED<\/strong>line of Abbott&#8217;s 31 October 2022 10(q) and its disclosure around its troubled segment:<\/span><\/p>\n<figure class=\"x-el x-el-figure c2-1 c2-2 c2-3x c2-i c2-h c2-21 c2-2c c2-29 c2-2a c2-43 c2-51 c2-3 c2-4 c2-5 c2-6 c2-7 c2-8\">\n<div>\n<div><span style=\"font-family: futural;\"><img decoding=\"async\" class=\"x-el x-el-img c2-1 c2-2 c2-k c2-21 c2-1x c2-1y c2-29 c2-2b c2-s c2-6b c2-4l c2-3 c2-4 c2-5 c2-6 c2-7 c2-8\" title=\"DATAREDline of ABT Quarterly Report Q3 2022\" src=\"https:\/\/img1.wsimg.com\/isteam\/ip\/b4167b12-c211-4a45-9c4b-489be14138f8\/Abbot%20Labs%20DATAREDline.PNG\/:\/cr=t:0%25,l:0%25,w:100%25,h:100%25\/rs=w:1280\" alt=\"DATAREDline of ABT Quarterly Report Q3 2022\" \/><\/span><\/div>\n<\/div><figcaption class=\"x-el x-el-figcaption c2-1 c2-2 c2-v c2-w c2-3d c2-29 c2-2b c2-4f c2-6c c2-6d c2-6e c2-6f c2-3 c2-6g c2-3e c2-10 c2-3f c2-3g c2-3h c2-3i\"><span style=\"font-family: futural;\">DATAREDline of ABT Quarterly Report Q3 2022<\/span><\/figcaption><\/figure>\n<p><span style=\"font-family: futural;\">In other words, if you are a shareholder invested in Abbott you do have things to be concerned about regarding Abbott Labs, since their documents score as consistently deceptive in the aggregate. But Abbott seems to be forthright, and likely cooperative, about any investigation done by the US Department of Justice into its Pediatric Nutritionals business.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>According to the Wall Street Journal on Friday, 20 January 2023,\u00a0the US Department of Justice is investigating Abbott Laboratories\u00a0due to a product recall of infant formula and the subsequent shutdown of its manufacturing at its Sturgis, Michigan plant in February 2022. You may remember that there was a consequent nationwide shortage of infant formula in [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":14252,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"<figure class=\"x-el x-el-figure c2-1 c2-2 c2-3x c2-i c2-h c2-21 c2-2c c2-29 c2-2a c2-43 c2-51 c2-3 c2-4 c2-5 c2-6 c2-7 c2-8\">\r\n<div>\r\n<div><span style=\"font-family: futural;\"><img class=\"x-el x-el-img c2-1 c2-2 c2-k c2-21 c2-1x c2-1y c2-29 c2-2b c2-s c2-6b c2-4l c2-3 c2-4 c2-5 c2-6 c2-7 c2-8\" title=\"DATA Assessment of Abbott Laboratories' Pediatric Nurtritionals\" src=\"https:\/\/img1.wsimg.com\/isteam\/ip\/b4167b12-c211-4a45-9c4b-489be14138f8\/Baby%20Screaming.jpg\/:\/cr=t:0%25,l:0%25,w:100%25,h:100%25\/rs=w:1280\" alt=\"DATA Assessment of Abbott Laboratories' Pediatric Nurtritionals\" \/><\/span><\/div>\r\n<\/div>\r\n<figcaption class=\"x-el x-el-figcaption c2-1 c2-2 c2-v c2-w c2-3d c2-29 c2-2b c2-4f c2-6c c2-6d c2-6e c2-6f c2-3 c2-6g c2-3e c2-10 c2-3f c2-3g c2-3h c2-3i\"><span style=\"font-family: futural;\">DATA Assessment of Abbott Laboratories' Pediatric Nurtritionals<\/span><\/figcaption><\/figure>\r\n<span style=\"font-family: futural;\"><em>By Jason Apollo Voss, CFA<\/em><\/span>\r\n\r\n<span style=\"font-family: futural;\">According to the Wall Street Journal on Friday, 20 January 2023,\u00a0<a class=\"x-el x-el-a c2-2w c2-2x c2-69 c2-v c2-w c2-x c2-j c2-6a c2-3 c2-30 c2-31 c2-11 c2-32\" href=\"https:\/\/www.wsj.com\/articles\/abbott-under-criminal-investigation-over-baby-formula-11674255871\" rel=\"\">the US Department of Justice is investigating Abbott Laboratories<\/a>\u00a0due to a product recall of infant formula and the subsequent shutdown of its manufacturing at its Sturgis, Michigan plant in February 2022. You may remember that there was a consequent nationwide shortage of infant formula in the spring of 2022. In turn this led to price gouging and many upset parents, and suspicions of major infant formula manufacturers.<\/span>\r\n\r\n<span style=\"font-family: futural;\">It is only natural to wonder if Abbott Labs is, or has been deceptive, about the baby formula shortage. Therefore, a check of Abbott\u2019s three 10(q)s subsequent to the recall and plant shutdown in Deception And Truth Analysis\u2019 DATAbase product makes sense. Are they, or are they not being forthright about this key business risk?<\/span>\r\n\r\n<span style=\"font-family: futural;\">Here is how we scored Abbott\u2026<\/span>\r\n\r\n<span style=\"font-family: futural;\">1. 2 May 2022 10(q)<\/span>\r\n\r\n<span style=\"font-family: futural;\">\u00a0\u00a0\u00a0a. Overall DATA Score = -14.57%<\/span>\r\n\r\n<span style=\"font-family: futural;\">\u00a0\u00a0\u00a0b. % of deceptive fragments = 85.71%<\/span>\r\n\r\n<span style=\"font-family: futural;\">2. 1 August 2022 10(q)<\/span>\r\n\r\n<span style=\"font-family: futural;\">\u00a0\u00a0\u00a0a. Overall DATA Score = -16.77%<\/span>\r\n\r\n<span style=\"font-family: futural;\">\u00a0\u00a0\u00a0b. % of deceptive fragments = 87.50%<\/span>\r\n\r\n<span style=\"font-family: futural;\">3. 31 October 2022 10(q)<\/span>\r\n\r\n<span style=\"font-family: futural;\">\u00a0\u00a0\u00a0a. Overall DATA Score = -18.14%<\/span>\r\n\r\n<span style=\"font-family: futural;\">\u00a0\u00a0\u00a0b. % of deceptive fragments = 87.50%<\/span>\r\n\r\n<span style=\"font-family: futural;\">From the above, it may seem as if the company is being deceptive, given their overall DATA Scores indicating deceptiveness. However, we found something remarkable in all three 10(q)s. Namely, that the\u00a0<em class=\"x-el x-el-span c2-2w c2-2x c2-3 c2-65 c2-13 c2-31 c2-66 c2-67\">only truthful fragments<\/em>\u00a0in each of these documents are Abbott\u2019s disclosures around its Pediatric Nutritionals, as it refers to its infant formula business. If you were a DATAbase Client you could verify this for yourself. Here is a screenshot of our DATA<strong class=\"x-el x-el-span c2-2w c2-2x c2-3 c2-65 c2-13 c2-3v c2-66\">RED<\/strong>line of Abbott's 31 October 2022 10(q) and its disclosure around its troubled segment:<\/span>\r\n<figure class=\"x-el x-el-figure c2-1 c2-2 c2-3x c2-i c2-h c2-21 c2-2c c2-29 c2-2a c2-43 c2-51 c2-3 c2-4 c2-5 c2-6 c2-7 c2-8\">\r\n<div>\r\n<div><span style=\"font-family: futural;\"><img class=\"x-el x-el-img c2-1 c2-2 c2-k c2-21 c2-1x c2-1y c2-29 c2-2b c2-s c2-6b c2-4l c2-3 c2-4 c2-5 c2-6 c2-7 c2-8\" title=\"DATAREDline of ABT Quarterly Report Q3 2022\" src=\"https:\/\/img1.wsimg.com\/isteam\/ip\/b4167b12-c211-4a45-9c4b-489be14138f8\/Abbot%20Labs%20DATAREDline.PNG\/:\/cr=t:0%25,l:0%25,w:100%25,h:100%25\/rs=w:1280\" alt=\"DATAREDline of ABT Quarterly Report Q3 2022\" \/><\/span><\/div>\r\n<\/div>\r\n<figcaption class=\"x-el x-el-figcaption c2-1 c2-2 c2-v c2-w c2-3d c2-29 c2-2b c2-4f c2-6c c2-6d c2-6e c2-6f c2-3 c2-6g c2-3e c2-10 c2-3f c2-3g c2-3h c2-3i\"><span style=\"font-family: futural;\">DATAREDline of ABT Quarterly Report Q3 2022<\/span><\/figcaption><\/figure>\r\n<span style=\"font-family: futural;\">In other words, if you are a shareholder invested in Abbott you do have things to be concerned about regarding Abbott Labs, since their documents score as consistently deceptive in the aggregate. But Abbott seems to be forthright, and likely cooperative, about any investigation done by the US Department of Justice into its Pediatric Nutritionals business.<\/span>","_et_gb_content_width":"","footnotes":""},"categories":[3,465],"tags":[454,455,451],"class_list":["post-14251","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-the-blog","category-d-a-t-a","tag-case-studies","tag-data-assessment","tag-dataredline"],"_links":{"self":[{"href":"https:\/\/jasonapollovoss.com\/web\/wp-json\/wp\/v2\/posts\/14251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jasonapollovoss.com\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jasonapollovoss.com\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jasonapollovoss.com\/web\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/jasonapollovoss.com\/web\/wp-json\/wp\/v2\/comments?post=14251"}],"version-history":[{"count":0,"href":"https:\/\/jasonapollovoss.com\/web\/wp-json\/wp\/v2\/posts\/14251\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jasonapollovoss.com\/web\/wp-json\/wp\/v2\/media\/14252"}],"wp:attachment":[{"href":"https:\/\/jasonapollovoss.com\/web\/wp-json\/wp\/v2\/media?parent=14251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jasonapollovoss.com\/web\/wp-json\/wp\/v2\/categories?post=14251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jasonapollovoss.com\/web\/wp-json\/wp\/v2\/tags?post=14251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}